Share this page on LinkedIn
Share This Page on Google+
Share This Page on Twitter
tell someone about this page print this page
You are here: Contents > 2014 > Volume 23 Number 5 September 2014 > CASE REPORT > Feasibility of Sutureless Valve Implantation in Reoperation for Degenerated 19 mm Aortic Valvular Bioprostheses

Feasibility of Sutureless Valve Implantation in Reoperation for Degenerated 19 mm Aortic Valvular Bioprostheses

Marco Vola1, Salvatore Campisi1, Amedeo Anselmi1, Claude Vaislic2, Jean-François Fuzellier1

1Cardiovascular Surgery Unit, University Hospital, St. Etienne, 2CMC Parly II, Le Chesnay, France

Background and aim of the study: Transcatheter aortic valve implantation (TAVI) is a promising option to treat degenerated aortic valve bioprostheses, and may involve Valve-in-Valve (ViV) procedures. Unfortunately, the ViV technique may provide an inadequate relief of stenosis in small-diameter degenerated bioprostheses, especially in the 19 mm valve subgroup. The study aim was to determine the feasibility and reliability of reoperating 19 mm degenerated bioprostheses, using a minimally invasive sutureless valve implantation.

Methods: Between March and December 2012, three reoperative procedures for degenerated 19 mm conventional aortic bioprostheses were performed at the authors’ unit. Stenosis was the main modality of structural deterioration. A partial upper ministernotomy approach was used, whereby part of the sewing ring


of the previous bioprosthesis was left in place and a 19 mm Medtronic Enable® sutureless valve was implanted in all cases.

Results: The average valve implantation time was 10.3 min. There were no cases of operative mortality or major morbidity. One permanent pacemaker was required. At discharge, transthoracic echocardiography showed no paravalvular leakages; the average transvalvular gradient was 16 mmHg. The one-year follow up showed no paravalvular leakages and unchanged gradients.

Conclusion: The use of a surgical sutureless valve after explanting a 19 mm degenerated bioprosthesis is feasible and effective for relieving stenosis. However, larger series are needed to confirm these preliminary results.

The Journal of Heart Valve Disease 2014;23:654-658

Feasibility of Sutureless Valve Implantation in Reoperation for Degenerated 19 mm Aortic Valvular Bioprostheses

Click the above hyperlink to view the article, right click (Ctrl click on a Mac) to open in a new browser window or tab.

Purchase this Article

Please click the button below to purchase this article. Single article purchases are provided at $50.00 per article. Upon clicking the button below, single article user account subscription details are requested and, upon successful payment, a single article user account is created. Single articles are availble in your account for seven days after purchase.